Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study

PR Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here

 Investigational Device Exemption (IDE) approval by the U.S. Food and Drug Administration (FDA) allows AcelRx to begin pivotal study of Niyad™

Single registration study with pre-agreed upon endpoints planned to initiate in Q4 2023 with topline data expected mid-2024; clinical site readiness is currently underway

Read more at prnewswire.com

Related Symbols

Symbol Last Chg %Chg
ACRX 0.8600 +0.0600 +7.50%
Acelrx Pharmaceutica

Most Popular News

Businessman touching the brain working of Artificial Intelligence (AI) Automation by Suttiphong Chandaeng via Shutterstock 1
Forget Palantir, This ‘Strong Buy’ AI Stock Beats PLTR on Value
Nvidia logo by Konstantin Savusia via Shutterstock 2
The Saturday Spread: Here’s How to Properly Trade the Nvidia (NVDA) Stock Discount
An image of a Tesla humanoid robot in front of the company logo Around the World Photos via Shutterstock 3
As Tesla Gets Ready to Remove Its Robotaxi Safety Drivers and Launch New FSD Model, Should You Buy TSLA Stock Here?
Blurred food and drink isles by themorningglory via iStock 4
JPMorgan Says This 1 Chip Stock Is a Strong Buy Now... And It’s Not What You Think It Is
Options button on browser by Pashalgnatov via iStock 5
Visa’s Unusual Options Activity on Thursday Signals 3 Smart Profit Moves You Can Make Now
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot